Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis

被引：0
|
作者：
Lugitsch, J. [1 ]
Hoeller, V [1 ]
Schwegel, N. [1 ]
Santner, V [1 ]
Gollmer, J. [1 ]
Kolesnik, E. [1 ]
Lipp, R. [2 ]
Niedrist, T. [3 ]
Rainer, P. [1 ]
Zirlik, A. [1 ]
Ablasser, K. [1 ]
Verheyen, N. [1 ]
Zach, D. [1 ]
机构：
[1] Med Univ Graz, Univ Herzzentrum, Abt Kardiol, Graz, Austria
[2] Med Univ Graz, Abt Onkol, Klin Innere Med, Graz, Austria
[3] Med Univ Graz, Klin Inst Med & Chem Labordiagnost, Graz, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2023年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24-2
引用
收藏
页码：S472 / S473
页数：2
相关论文
共 50 条
  • [41] Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction
    Griffin, Jan M.
    Maurer, Mathew S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (01) : 59 - 66
  • [42] Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy
    Ptaszynska-Kopczynska, Katarzyna
    Szpakowicz, Anna
    Marcinkiewicz-Siemion, Marta
    Lisowska, Anna
    Waszkiewicz, Ewa
    Witkowski, Marcin
    Jakim, Piotr
    Galar, Bogdan
    Musial, Wlodzimierz J.
    Kaminski, Karol A.
    ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (05) : 1069 - 1077
  • [43] High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with chronic atrial fibrillation
    Roldan, V.
    Marin, F.
    Diaz, J.
    Jover, E.
    Manzano-Fernandez, S.
    Romera, M.
    Casas, T.
    Valdes, M.
    Vicente, V.
    Lip, G. Y.
    EUROPEAN HEART JOURNAL, 2012, 33 : 54 - 54
  • [44] Riociguat in transthyretin cardiac amyloidosis - experiences from a prospective heart failure registry
    Duca, F. Franz
    Zotter-Tufaro, C.
    Binder, C.
    Kammerlander, A. A.
    Boerries, B.
    Agis, H.
    Kain, R.
    Mascherbauer, J.
    Bonderman, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 461 - 462
  • [45] Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis
    Okamoto, Nao
    Kubo, Toru
    Nakashima, Yasuteru
    Ochi, Yuri
    Takahashi, Asa
    Baba, Yuichi
    Hirota, Takayoshi
    Yamasaki, Naohito
    Kitaoka, Hiroaki
    INTERNAL MEDICINE, 2020, 59 (03) : 339 - 343
  • [46] High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation: a rebuttal
    Providencia, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (11) : 2913 - 2913
  • [47] Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6
    Dolenc, Jure
    Sebestjen, Miran
    Vrtovec, Bojan
    Kozelj, Mirta
    Haddad, Francois
    BIOMARKERS, 2014, 19 (05) : 385 - 390
  • [48] Therapeutic use of dopamine and beta-blockers modulates plasma interleukin-6 levels in patients with congestive heart failure
    Mabuchi, N
    Tsutamoto, T
    Kinoshita, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (06) : S87 - S91
  • [49] Interleukin-6 response to milrinone and enalapril in heart failure
    Deng, MC
    Erren, M
    Leschnik, J
    Hoffmann, N
    Brisse, B
    Scheld, HH
    CIRCULATION, 1997, 96 (08) : 1797 - 1797
  • [50] Plasma interleukin-6 levels in Mediterranean spotted fever
    J. Oristrell
    M. Sampere
    M. J. Amengual
    B. Font
    F. Segura
    European Journal of Clinical Microbiology and Infectious Diseases , 2004, 23 : 417 - 418
12345